Systemic Therapy for Tumor Control in Well-Differentiated Metastatic Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline Q and A [0.03%]
welldifferentiated胃肠道胰腺神经内分泌肿瘤转移灶的系统治疗：ASCO指南问答
Jaydira Del Rivero,Erin B Kennedy,Kimberley Perez
Jaydira Del Rivero
Understanding Barriers and Facilitators to High-Quality Cancer Care Among Veterans With Lung Cancer: A Qualitative Study [0.03%]
一项定性研究：了解退伍军人肺癌患者高质量癌症治疗的障碍与促进因素
Christopher Lopez,Ariana Murillo,Millie Das et al.
Christopher Lopez et al.
Purpose: Veteran populations have higher lung cancer incidence and worse overall survival compared with non-Veteran populations. Although recent clinical advancements have reduced lung cancer death rates, these advances a...
Prevalence of Adverse Event Reporting in Adolescents and Young Adults Enrolled in Cancer Clinical Trials [0.03%]
癌症临床试验中青少年和年轻成人不良事件报告的流行率
Cole Wayant,Kyle Fitzgerald,Christian Hemmerich et al.
Cole Wayant et al.
Purpose: Survival for adolescents and young adults (AYAs) with cancer has improved over the past few decades, and targeted approaches are needed to further improve outcomes. Limited reports suggest that AYAs tolerate canc...
Sociodemographic Inequities in Telemedicine Use Among US Patients Initiating Treatment in Community Cancer Centers During the Ongoing COVID-19 Pandemic, 2020-2022 [0.03%]
2020-2022年新冠大流行期间美国社区癌症中心开始治疗的患者使用远程医疗的社会人口学差异性
Jenny S Guadamuz,Xiaoliang Wang,Trevor J Royce et al.
Jenny S Guadamuz et al.
Purpose: Although telemedicine was seen as a way to improve cancer care during the coronavirus disease (COVID-19) pandemic, there is limited information regarding inequities in its uptake. This study assessed sociodemogra...
Sustainable Integration of US Food and Drug Administration-Approved Biosimilars: Pharmacy- Versus Physician-Driven Change [0.03%]
美国食品药品监督管理局批准的生物类似药的可持续整合：药师驱动与医师驱动的变革效果比较
David M Waterhouse,Patrick Ward,David R Drosick et al.
David M Waterhouse et al.
Purpose: Biosimilars are clinically equivalent to branded products yet cost significantly less. Interchangeability is a US Food and Drug Administration (FDA) designation that allows generic drugs to be substituted for ref...
Health Care Contact Days Experienced by Decedents With Advanced GI Cancer [0.03%]
晚期胃肠道癌症患者的医疗接触日及寿命丢失天数
Vishal R Patel,Vidhyalakshmi Ramesh,Alexander K Tsai et al.
Vishal R Patel et al.
Purpose: Frequent visits to health care facilities can be time intensive and all-consuming for people with cancer. We measured health care contact days (days with healthcare contact outside the home) among decedents with ...
Feasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone App [0.03%]
使用智能手机应用程序收集患者报告的结果监测早期乳腺癌内分泌治疗第一年症状的可行性研究
Karen Lisa Smith,Hua-Ling Tsai,David Lim et al.
Karen Lisa Smith et al.
Purpose: Treatment-associated symptoms drive early discontinuation of adjuvant endocrine therapy (ET) for breast cancer. We hypothesized that symptom monitoring with electronic patient-reported outcomes (ePROs) during adj...
Path Less Traveled: Targeting Rare Driver Oncogenes in Non-Small-Cell Lung Cancer [0.03%]
罕见驱动基因在非小细胞肺癌中的作用及靶向治疗研究
Sun Min Lim,Jii Bum Lee,Yuko Oya et al.
Sun Min Lim et al.
Over the past decade, tremendous efforts have been made in the development of targeted agents in non-small-cell lung cancer (NSCLC) with nonsquamous histology. Pivotal studies have used next-generation sequencing to select the patient popul...
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial [0.03%]
前列腺癌患者的前期视频教育与遗传咨询的比较：多中心随机对照试验-ProGen试验
Huma Q Rana,Jill E Stopfer,Michelle Weitz et al.
Huma Q Rana et al.
Purpose: Germline genetic testing (GT) is recommended for men with prostate cancer (PC), but testing through traditional models is limited. The ProGen study examined a novel model aimed at providing access to GT while pro...
Randomized Controlled Trial
JCO oncology practice. 2023 Nov;19(11):1069-1079. DOI:10.1200/OP.23.00007 2023
Lessons Learned and Practice Pearls: Optimal Integration of Electronic Patient-Reported Outcomes in the Medical Oncology Clinic [0.03%]
电子化患者报告结局在肿瘤科临床应用的实践要点及经验总结
Ciara C O&#x;Sullivan,Jennifer R Cracchiolo,Amye J Tevaarwerk
Ciara C O&#x;Sullivan